Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21.

2.

Statin use and breast cancer: prospective results from the Women's Health Initiative.

Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT; Women's Health Initiative Research Group.

J Natl Cancer Inst. 2006 May 17;98(10):700-7.

PMID:
16705124
3.

Statin use and prostate cancer risk in a large population-based setting.

Boudreau DM, Yu O, Buist DS, Miglioretti DL.

Cancer Causes Control. 2008 Sep;19(7):767-74. doi: 10.1007/s10552-008-9139-4. Epub 2008 Mar 6.

4.

Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.

Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1868-76. doi: 10.1158/1055-9965.EPI-13-0562. Epub 2013 Aug 23.

5.

Statin use and female reproductive organ cancer risk in a large population-based setting.

Yu O, Boudreau DM, Buist DS, Miglioretti DL.

Cancer Causes Control. 2009 Jul;20(5):609-16. doi: 10.1007/s10552-008-9271-1. Epub 2008 Nov 30.

6.

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.

J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. doi: 10.1093/jnci/djr291. Epub 2011 Aug 2.

7.

The association between statins and cancer incidence in a veterans population.

Farwell WR, Scranton RE, Lawler EV, Lew RA, Brophy MT, Fiore LD, Gaziano JM.

J Natl Cancer Inst. 2008 Jan 16;100(2):134-9. doi: 10.1093/jnci/djm286. Epub 2008 Jan 8.

PMID:
18182618
8.

Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.

Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1028-33. doi: 10.1158/1055-9965.EPI-07-0726. Epub 2008 May 7.

9.

Lipophilic statin use and risk of breast cancer subtypes.

Woditschka S, Habel LA, Udaltsova N, Friedman GD, Sieh W.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2479-87. doi: 10.1158/1055-9965.EPI-10-0524. Epub 2010 Aug 20. Erratum in: Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):1001-3.

10.

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR.

Cancer. 2004 Jun 1;100(11):2308-16.

11.

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.

Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B.

Breast Cancer Res Treat. 2008 Jun;109(3):573-9. Epub 2007 Aug 3.

12.

Statins and breast cancer stage and mortality in the Women's Health Initiative.

Desai P, Lehman A, Chlebowski RT, Kwan ML, Arun M, Manson JE, Lavasani S, Wasswertheil-Smoller S, Sarto GE, LeBoff M, Cauley J, Cote M, Beebe-Dimmer J, Jay A, Simon MS.

Cancer Causes Control. 2015 Apr;26(4):529-39. doi: 10.1007/s10552-015-0530-7. Epub 2015 Mar 4.

13.

Statin use and the risk of breast and prostate cancer.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Shapiro S.

Epidemiology. 2002 May;13(3):262-7.

PMID:
11964926
14.

Statin use and breast cancer survival: a nationwide cohort study from Finland.

Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E.

PLoS One. 2014 Oct 20;9(10):e110231. doi: 10.1371/journal.pone.0110231. eCollection 2014.

15.

Statins and the risk of lung, breast, and colorectal cancer in the elderly.

Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S.

Circulation. 2007 Jan 2;115(1):27-33. Epub 2006 Dec 18.

16.

Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.

Alexandre L, Clark AB, Bhutta HY, Chan SS, Lewis MP, Hart AR.

Gastroenterology. 2016 Apr;150(4):854-65.e1; quiz e16-7. doi: 10.1053/j.gastro.2015.12.039. Epub 2016 Jan 9.

PMID:
26775632
17.

Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.

Jagtap D, Rosenberg CA, Martin LW, Pettinger M, Khandekar J, Lane D, Ockene I, Simon MS.

Cancer. 2012 Oct 15;118(20):5124-31. doi: 10.1002/cncr.27497. Epub 2012 Mar 20.

18.

Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Nickels S, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J.

PLoS One. 2013 Sep 25;8(9):e75088. doi: 10.1371/journal.pone.0075088. eCollection 2013.

19.

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37. doi: 10.1158/1055-9965.EPI-13-0414. Epub 2013 Jul 5.

20.

Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative.

Simon MS, Desai P, Wallace R, Wu C, Howard BV, Martin LW, Schlecht N, Liu S, Jay A, LeBlanc ES, Rohan T, Manson J.

Cancer Causes Control. 2016 Mar;27(3):415-23. doi: 10.1007/s10552-016-0717-6. Epub 2016 Feb 9.

PMID:
26857832

Supplemental Content

Support Center